Clinical trial
Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Primary Hip and Knee Arthroplasty? Multicenter Randomized Controlled Trial
NCT05972603 is registered in ClinicalTrials.gov with Independent Public Healthcare Center in Rypin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Primary Hip and Knee Arthroplasty? Multicenter Randomized Controlled Trial
- Lead sponsor
- Independent Public Healthcare Center in Rypin
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis of hip, osteoarthritis, hip, osteoarthritis, knee, rheumatoid arthritis